Tg Therapeutics (TGTX) Gross Profit (2021 - 2025)
Historic Gross Profit for Tg Therapeutics (TGTX) over the last 5 years, with Q3 2025 value amounting to $133.6 million.
- Tg Therapeutics' Gross Profit rose 7925.89% to $133.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $453.9 million, marking a year-over-year increase of 9411.03%. This contributed to the annual value of $290.5 million for FY2024, which is 3233.58% up from last year.
- Tg Therapeutics' Gross Profit amounted to $133.6 million in Q3 2025, which was up 7925.89% from $122.2 million recorded in Q2 2025.
- In the past 5 years, Tg Therapeutics' Gross Profit ranged from a high of $162.3 million in Q3 2023 and a low of $77000.0 during Q4 2022
- In the last 5 years, Tg Therapeutics' Gross Profit had a median value of $61.6 million in 2024 and averaged $62.3 million.
- Per our database at Business Quant, Tg Therapeutics' Gross Profit surged by 17631956.52% in 2023 and then plummeted by 5407.56% in 2024.
- Over the past 5 years, Tg Therapeutics' Gross Profit (Quarter) stood at $654000.0 in 2021, then plummeted by 88.23% to $77000.0 in 2022, then surged by 46805.19% to $36.1 million in 2023, then surged by 156.9% to $92.8 million in 2024, then soared by 44.0% to $133.6 million in 2025.
- Its last three reported values are $133.6 million in Q3 2025, $122.2 million for Q2 2025, and $105.3 million during Q1 2025.